Cover Image

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer

Aim: Sarcopenia and skeletal muscle density (SMD) have been shown to be both predictive and prognostic marker in oncology. Advanced lung cancer inflammation index (ALI) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). Computed tomography (CT) enables skeletal muscle...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abhishek Mahajan (Author), Devendra Goyal (Author), Ujjwal Agarwal (Author), Vijay Patil (Author), Shreya Shukla (Author), Vanita Noronha (Author), Amit Joshi (Author), Nandini Menon (Author), Kumar Prabhash (Author)
Format:	Book
Published:	Open Exploration Publishing Inc., 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Oral metronomic therapy in head and neck cancer - Authors' reply
by: Vijay Patil, et al.
Published: (2021)

Patient advocacy and support groups in India: focus on lung cancer
by: Vanita Noronha, et al.
Published: (2024)

Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer
by: Abhishek Mahajan, et al.
Published: (2023)

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer
by: Abhishek Mahajan, et al.
Published: (2024)

Uniqueness of lung cancer in Southeast Asia
by: Vanita Noronha, et al.
Published: (2024)

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy
by: Jyoti Bhagatram Sharma, et al.
Published: (2021)

Advances in combined neuroendocrine carcinoma of lung cancer
by: Zesen Han, et al.
Published: (2024)

Symptom clusters in Thai patients with advanced lung cancer
by: Noppamat Pudtong
Published: (2013)

Racotumomab therapeutic vaccine in an elderly with advanced lung cancer
by: Tatiana Hernández Casola, et al.
Published: (2020)

The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
by: Mengmeng Song, et al.
Published: (2022)

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
by: Ilaria Durosini, et al.
Published: (2021)

Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
by: Xian-Guang Bai, et al.
Published: (2022)

Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study
by: Keigo Koda, et al.
Published: (2022)

A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer
by: Himani Aggarwal, et al.
Published: (2023)

Initial Systemic Treatment of Advanced Non-small Cell Lung Cancer
by: Muhammad Kamran Siddique, et al.
Published: (2019)

The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung Cancer
by: Mogenet A, et al.
Published: (2021)

Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
by: Lin CY, et al.
Published: (2024)

New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
by: Jiaqi Feng, et al.
Published: (2024)

Clinical development of nintedanib for advanced non-small-cell lung cancer
by: Takeda M, et al.
Published: (2015)

Caregiver Burden of Advance Lung Cancer Patient: a concept analysis
by: Dimas Ria Angga Pribadi, et al.
Published: (2022)

Translation and validation of the Chinese version of the acceptance and action questionnaire for cancer in patients with advanced lung cancer
by: Huiyuan Li, et al.
Published: (2023)

Advance in researches on relationship between human microbiome and lung cancer: a review
by: Jia-li CHEN, et al.
Published: (2023)

Advanced Small Cell Lung Cancer with Cerebellar Metastases - A Case Report
by: Zhi Xiong Chong, et al.
Published: (2015)

Advanced Small Cell Lung Cancer with Cerebellar Metastases - A Case Report
by: Zhi Xiong Chong, et al.
Published: (2015)

Assessment of Financial Toxicity Among Patients With Advanced Lung Cancer in Western China
by: Tianqi Xu, et al.
Published: (2022)

Estimated costs of advanced lung cancer care in a public reference hospital
by: Renata Erthal Knust, et al.
Published: (2017)

Recent advances to address challenges in extracellular vesicle-based applications for lung cancer
by: Gaigai Huang, et al.
Published: (2024)

Prognostic value of activin A level in patients with advanced lung cancer and sarcopenia
by: V. V. Kechedzhyiev
Published: (2024)

HUNCHEST projects-advancing low-dose CT lung cancer screening in Hungary
by: Anna Kerpel-Fronius, et al.
Published: (2024)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
by: Yang Fu, et al.
Published: (2022)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
by: Enriqueta Felip, et al.
Published: (2008)

Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
by: Le AD, et al.
Published: (2017)

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
by: Thomas Rodier, et al.
Published: (2022)

Predictive Efficacy of the Advanced Lung Cancer Inflammation Index in Hepatocellular Carcinoma After Hepatectomy
by: Qiu X, et al.
Published: (2024)

GEMCITABINE / PLATINUM VS. VINORELBINE- PLATINUM IN PATIENTS WITH ADVANCED NON- SMALL- CELL LUNG CANCER
by: Deyan Davidov
Published: (2008)

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan
by: Shiou-Han Wang, et al.
Published: (2011)

A case of de novo psoriasis induced by atezolizumab in a patient with advanced lung cancer
by: Shigeruko Iijima, et al.
Published: (2019)

Next Generation of Advanced Non-Small Cell Lung Cancer Therapy: Targeted and Immuno-Therapies
by: Sze Wah Samuel Chan, et al.
Published: (2020)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
by: Guiyuan Xiang, et al.
Published: (2021)

The relationship between quality of life in sarcopenia and skeletal muscle index in patients with advanced lung cancer
by: V. Kechedzhyiev
Published: (2021)